MicroRNAs and JAK/STAT3 signaling: A new promising therapeutic axis in blood cancers-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

MicroRNAs and JAK/STAT3 signaling: A new promising therapeutic axis in blood cancers

Published:2021-12 Issue: Volume: Page:
ISSN:2352-3042
Container-title:Genes & Diseases
language:en
Short-container-title:Genes & Diseases

Author:

Sajjadi-Dokht Mehdi,Merza Mohamad Talar Ahmad,Rahman Heshu Sulaiman,Maashi Marwah Suliman,Danshina Svetlana,Shomali Navid,Solali Saeed,Marofi Faroogh,Zeinalzadeh Elham,Akbari Morteza,Adili Ali,Aslaminabad Ramin,Hagh Majid Farshdousti,Jarahian Mostafa

Publisher

Elsevier BV

Subject

Cell Biology,Genetics(clinical),Molecular Biology,Biochemistry

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ponatinib and STAT5 Inhibitor Pimozide Combined Synergistic Treatment Applications Potentially Overcome Drug Resistance via Regulating the Cytokine Expressional Network in Chronic Myeloid Leukemia Cells;Journal of Interferon & Cytokine Research;2024-04-01

2. Targeting CDK9 in Cancer: An Integrated Approach of Combining In Silico Screening with Experimental Validation for Novel Degraders;Current Issues in Molecular Biology;2024-02-22

3. Hijacking 5-Fluorouracil Chemoresistance in Triple Negative Breast Cancer via microRNAs-Loaded Chitosan Nanoparticles;International Journal of Molecular Sciences;2024-02-08

4. MicroRNAs: Potential prognostic and theranostic biomarkers in chronic lymphocytic leukemia;eJHaem;2024-02

5. The role of the JAK/STAT3 signaling pathway in acquired corneal diseases;Experimental Eye Research;2024-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP